期刊文献+

参麦注射液防治恶性肿瘤化疗所致心脏毒性的护理方式 被引量:4

Nursing care of Shenmai injection in preventing and treating cardiac toxicity induced by chemotherapy in malignant tumors
原文传递
导出
摘要 目的探讨参麦注射液防治恶性肿瘤化疗所致心脏毒性的护理方式;方法选取我院2017年2月-2018年2月收治的恶性肿瘤患者90例我研究对象,比较两组患者心脏功能及心肌酶谱;结果观察组患者采用针对性护理,心脏功能及心肌酶谱显著优于对照组(P均<0.05);结论恶性肿瘤患者采用化疗治疗,同时辅助参麦注射液和针对性护理可有效保护心脏功能,提高临床疗效,值得推荐。 OBJECTIVE To explore the nursing methods of shenmai injection for the prevention and treatment of cardiac toxicity caused by chemotherapy.METHODS I selected 90 patients with malignant tumors admitted to our hospital from February 2017 to February 2018,and compared the cardiac function and myocardial enzyme spectrum between the two groups.RESULTS The patients in the observation group received targeted nursing,and the cardiac function and myocardial enzyme spectrum were significantly superior to the control group(all P<0.05).CONCLUSIONS The treatment of malignant tumor patients with chemotherapy and the assistance of shenmai injection and targeted nursing can effectively protect the cardiac function and improve the clinical efficacy,which is worthy of recommendation.
作者 杨鹃蔚 李森 董娟娟 YANG Juan-wei;LI Miao;DONG Juan-juan(Southern Hospital of Southern Medi;Chinese People's Liberation Army188 Hospital,Chaozhou 521000,P.R.China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2018年第S2期289-290,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 恶性肿瘤 化疗 针对性护理 malignant tumor Chemotherapy Targeted care
  • 相关文献

参考文献3

二级参考文献46

  • 1张微微,陈越,钱义明.参附注射液对含阿霉素类化疗方案减毒增效作用的临床观察[J].河南中医,2007,27(4):70-71. 被引量:11
  • 2邢国臣 张存启 周伟华.环磷酰胺、吡喃阿霉素、顺铂时间治疗卵巢癌26例[J].浙江肿瘤,1998,4(3):197-197.
  • 3Word Cancer Report. 2014[EB/OL]. 2014-02-08.http://www.wpro 14wldo vtu short10022014 world _cancer_report/en/.
  • 4Gillespie HS, McGann C J, Wilson BD. Noninvasive diagnosis of ehemother-apy related cardiotoxicity [J]. Curt Cardiol Rev, 2011, 7 (4): 234-244.
  • 5Albini A, Pannesi G, Donatelli F, et al. Cardiotoxicity of anticancer drugs: the need for eardio-oncology and cardio-oneological preven- tion [J]. J Natl Cancer Inst, 2010, 102(1): 14-25.
  • 6Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Surviv- al of cancer patients diagnosed in 1995-1999. Results and corn- mentary[J]. Eur J Cancer, 2009, 45(6): 931-991.
  • 7OelTmger KC, Mertens AC, Sklar CA, et al. Chronic health condi- tions in adult survivors of childhood cancer [J]. N Engl J Med, 2006, 355(15): 1572-1582.
  • 8Zuppinger C, Timolati F, Suter TM. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy [J]. Cardiovasc Toxicol, 2007, 7(2): 61-66.
  • 9Geiger S, Lange V, Suhl P, et al. Anticancer therapy induced cardio- toxicity: review of the literature [J]. Anticancer Drugs, 2010, 21(6): 578-590.
  • 10Jirkovsky E, Popelova O, Krivakova-Stankova P, et al. Chronic an- thracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondri- al biogenesis pathways [J]..l Pharmacol Exp Ther, 2012, 343(2): 468-478.

共引文献1063

同被引文献43

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部